leisure time -WSS

leisure time

author：leisure time 2025-09-06 02:11:28 - browse：3

Biotech startup Generate Biomedicines, which uses artificial intelligence to find new drugs, raised $273 million in a Series C funding round from investors including pharma company Amgen and the VC arm of AI giant NVIDIA.

Generate was founded in 2018 by venture-creation firm Flagship Pioneering to use machine learning algorithms to identify antibodies, peptides, cell therapies, and other medicines. It launched its first clinical trial in July for a Covid monoclonal antibody, and is working on starting another clinical trial for an asthma treatment.

The biotech, which is based in Somerville, Mass., has big plans for the next couple of years: It has another 15 drug candidates in the works and plans to introduce 10 more annually, CEO Mike Nally told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Black vets could get higher VA benefits if race not used in lung test

WSS

China dismisses criticism of top diplomat's comments appearing to push for race

Following judge's order, DOJ releases slightly less

The creative science of coining drug names

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

China dismisses criticism of top diplomat's comments appearing to push for race

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

focus

leisure time

focus

In Memoriam: Notable people who died in 2023

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

The high cost of giving birth even with insurance

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Guidelines to prevent youth baseball injuries need more muscle

China dismisses criticism of top diplomat's comments appearing to push for race

Activists slam private health insurers over coverage restrictions

Empower primary care with adequate payments and technology

Hepatitis C has a cure — but many Americans still lack access to it

AI for drug discovery: Experts on separating hype from reality

focus

Pope Francis asks Church to identify 21st

EU moves toward latest gene techniques in food production to counter climate change, shortages

Crowdfunding for medical bills sidesteps core problem, author says

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

EU moves toward latest gene techniques in food production to counter climate change, shortages

AltruBio raises $225 million to develop ulcerative colitis drug

focus

entertainment

focus

hotspot